Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Ulcerative Colitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00984568
What this trial is testing

Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)

Who this might be right for
Colitis, Ulcerative
Merck Sharp & Dohme LLC 28
Testing effectiveness (Phase 2)Study completedNCT01294410
What this trial is testing

Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Bristol-Myers Squibb 305
Post-approval studies (Phase 4)Study completedNCT01408810
What this trial is testing

Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Grupo de Estudo da Doença Inflamatória Intestinal 21
Large-scale testing (Phase 3)Study completedNCT03915769
What this trial is testing

To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Celgene 198
Testing effectiveness (Phase 2)Study completedNCT03760003
What this trial is testing

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 355
Not applicableEnrolling By InvitationNCT07721441
What this trial is testing

Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL）

Who this might be right for
Ulcerative Colitis (UC)
Tang-Du Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT07158242
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche 100
Testing effectiveness (Phase 2)Study completedNCT01647516
What this trial is testing

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Celgene 199
Testing effectiveness (Phase 2)Ended earlyNCT02895100
What this trial is testing

Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Protagonist Therapeutics, Inc. 98
Early research (Phase 1)Ended earlyNCT07029971
What this trial is testing

A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Vial Australia Pty Ltd 16
Not applicableStudy completedNCT00791557
What this trial is testing

Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

Who this might be right for
Pyoderma GangrenosumCrohn's DiseaseUlcerative Colitis+1 more
University Hospitals Cleveland Medical Center 2
Testing effectiveness (Phase 2)Ended earlyNCT01671956
What this trial is testing

Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
Alexion Pharmaceuticals, Inc. 32
Large-scale testing (Phase 3)UnknownNCT01494857
What this trial is testing

Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Clalit Health Services 200